Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

Author:

Illes Peter12ORCID,Müller Christa E.3ORCID,Jacobson Kenneth A.4,Grutter Thomas5,Nicke Annette6,Fountain Samuel J.7,Kennedy Charles8ORCID,Schmalzing Günther9,Jarvis Michael F.10,Stojilkovic Stanko S.11,King Brian F.12,Di Virgilio Francesco13ORCID

Affiliation:

1. Rudolf Boehm Institute for Pharmacology and Toxicology University of Leipzig Leipzig Germany

2. International Collaborative Centre on Big Science Plan for Purinergic Signalling Chengdu University of Traditional Chinese Medicine Chengdu China

3. PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry University of Bonn Bonn Germany

4. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD USA

5. University of Strasbourg, Centre National de la Recherche Scientifique, CAMB UMR 7199 Strasbourg France

6. Walther Straub Institute for Pharmacology and Toxicology Ludwig‐Maximilians‐Universität München Munich Germany

7. Faculty of Science University of East Anglia Norwich UK

8. Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK

9. Institute of Clinical Pharmacology RWTH Aachen University Aachen Germany

10. Global Medical Affairs Abbvie, Inc. North Chicago IL USA

11. Section on Cellular Signaling, The Eunice Kennedy Shiver National Institute of Child Health and Human Development National Institutes of Health Bethesda MD USA

12. Department of Neuroscience, Physiology and Pharmacology University College London London UK

13. Department of Medical Sciences, Section of Experimental Medicine University of Ferrara Ferrara Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Università degli Studi di Ferrara

Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía

Deutsche Forschungsgemeinschaft

Horizon 2020 Framework Programme

State Administration of Foreign Experts Affairs

Chengdu University of Traditional Chinese Medicine

Publisher

Wiley

Subject

Pharmacology

Cited by 206 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3